Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Christina Baggot"'
Autor:
Claire Johns, Courtney Erickson, Ashley Jacobs, Jennifer Moon, Christina Baggott, Regina Dagher, Helen Nadel, Jay Balagtas, Catherine Aftandilian, Sneha Ramakrishna, Norman Lacayo, Kara L. Davis, Elliot Stieglitz, Liora Schultz
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Standard testing for disease evaluation in B-cell acute lymphoblastic leukemia (B-ALL) includes examination of the bone marrow and cerebrospinal fluid. Radiographic or functional imaging are indicated when clinical signs of non-CNS extramedullary dis
Externí odkaz:
https://doaj.org/article/804f63d9ff31435e95f8f42657723ec2
Autor:
Matire Harwood, Ruth Semprini, Hilary Pinnock, Stuart Dalziel, Amy Hai Yan Chan, Job F M van Boven, Lisa Wood, Alana Cavadino, Syed Ahmar Shah, Christina Baggott, Clare Wall, Farhaan Mirza, Braden Te Ao, Joanna Hikaka, Jeff Harrison, Catherina L Chang, Rajshri Roy, Amber A Eikholt, Dianna Gibbs, Mariana Hudson, Muhammed Asif Naeem, Kevin C H Tsang, Aron Jeremiah, Binu Nisal Abeysinghe, Partha Roop
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Introduction Asthma attacks are a leading cause of morbidity and mortality but are preventable in most if detected and treated promptly. However, the changes that occur physiologically and behaviourally in the days and weeks preceding an attack are n
Externí odkaz:
https://doaj.org/article/cc57e24b55a844118b9d7a426a352436
Autor:
Courtney Erickson, Sharon Mavroukakis, Lindsey Rasmussen, Emily Egeler, Rebecca Richards, Sonia Partap, John S. Tamaresis, Aaron Mochizuki, Anne Cunniffe Marcy, Kristen W. Yeom, Jennifer Moon, Harshini Chinnasamy, Steven A. Feldman, Gerald A. Grant, Zach Ehlinger, Crystal L. Mackall, Agnes Reschke, Christina Baggot, Paul G. Fisher, Liora M. Schultz, Shabnum Patel, Kayla Landrum, Zina Good, Michelle Monje, Cynthia J. Campen, Michael Kunicki, Michelle Celones, Timothy T. Cornell, Jasia Mahdi, Sreevidya Kurra, Hannes Vogel, Robbie G. Majzner, Valentin Barsan, Kara L. Davis, Bita Sahaf, Angus Toland, Sneha Ramakrishna
Publikováno v:
Neuro-Oncology
Introduction We are conducting a Phase I clinical trial utilizing chimeric antigen receptor (CAR) T-cells targeting GD2 (NCT04196413) for H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) and spinal cord diffuse midline glioma (DMG). Cerebrospina
Autor:
Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather Stefanski, Julie-An Talano, Amy Moskop, Susanne Baumeister, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Stacy Cooper, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy Keating, Vanessa Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102268- (2023)
Summary: Background: Tisagenlecleucel was approved by the Food and Drug Administration (FDA) in 2017 for refractory B-cell acute lymphoblastic leukemia (B-ALL) and B-ALL in ≥2nd relapse. Outcomes of patients receiving commercial tisagenlecleucel up
Externí odkaz:
https://doaj.org/article/20c0403244324301a828fb1de6d7904b
Autor:
Emily Vettese, Farha Sherani, Allison A. King, Lolie Yu, Catherine Aftandilian, Christina Baggott, Vibhuti Agarwal, Ramamoorthy Nagasubramanian, Kara M. Kelly, David R. Freyer, Etan Orgel, Scott M. Bradfield, Wade Kyono, Michael Roth, Lisa M. Klesges, Melissa Beauchemin, Allison Grimes, George Tomlinson, L. Lee Dupuis, Lillian Sung
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background There is substantial heterogeneity in symptom management provided to pediatric patients with cancer. The primary objective was to describe the adaptation process and specific adaptation decisions related to symptom management care
Externí odkaz:
https://doaj.org/article/9a3f34aa87ea426ca2b0df1fb7257623
Autor:
Maya Eylon, Snehit Prabhu, Samuel John, Maxwell J. M. King, Dhruv Bhatt, Kevin J. Curran, Courtney Erickson, Nicole A. Karras, Christine L. Phillips, Prakash Satwani, Michelle Hermiston, Erica Southworth, Susanne H. C. Baumeister, Julie-An Talano, Margaret L. MacMillan, Jenna Rossoff, Challice L. Bonifant, Gary Doug Myers, Rayne H. Rouce, Keri Toner, Timothy A. Driscoll, Emmanuel Katsanis, Dana B. Salzberg, Deborah Schiff, Satiro N. De Oliveira, Christian M. Capitini, Holly L. Pacenta, Thomas Pfeiffer, Niketa C. Shah, Van Huynh, Jodi L. Skiles, Ellen Fraint, Kevin O. McNerney, Troy C. Quigg, Joerg Krueger, John A. Ligon, Vanessa A. Fabrizio, Christina Baggott, Theodore W. Laetsch, Liora M. Schultz
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionMediport use as a clinical option for the administration of chimeric antigen receptor T cell (CAR T cell) therapy in patients with B-cell malignancies has yet to be standardized. Concern for mediport dislodgement, cell infiltration, and i
Externí odkaz:
https://doaj.org/article/63c1f7316ab94ecab4e03921e246dcfd
Autor:
Crystal L Mackall, Christina Baggott, Kara Lynn Davis, Liora Schultz, Ann Walkush, Courtney Erickson, Sneha Ramakrishna, Catherine Aftandilian, Norman Lacayo, Helen Ruth Nadel, Jean Oak
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 2 (2023)
Background: Chimeric antigen receptor (CAR) T cell therapy is an effective salvage therapy for pediatric relapsed B-cell acute lymphoblastic leukemia (B-ALL), yet is challenged by high rates of post-CAR relapse. Literature describing specific relapse
Externí odkaz:
https://doaj.org/article/0898e66bc0de4d3099ca0993cfc0cfe9
Autor:
Matire Harwood, Richard Beasley, Christina Baggott, William Mark Magnus Levack, Sally Hurford, Amy Chan
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Externí odkaz:
https://doaj.org/article/8182f4d4e05442108cab0e5c6ffbced7
Autor:
Donna L. Johnston, Shannon Hyslop, Deborah Tomlinson, Christina Baggott, Paul Gibson, Andrea Orsey, David Dix, Vicky Price, Magimairajan Vanan, Carol Portwine, Susan Kuczynski, Brenda Spiegler, George A. Tomlinson, Laura Lee Dupuis, Lillian Sung
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1750-1755 (2018)
Abstract Objectives were to describe any bothersome symptom and severely bothersome symptoms in inpatient children with cancer and hematopoietic stem cell transplant (HSCT) recipients. We included children 8–18 years of age with cancer or HSCT reci
Externí odkaz:
https://doaj.org/article/ee6f59f2d7a44ab5916d0d6f9d62ad51